First Script saw continued decreasing opioid trends across our retail and mail-order programs in 2019, even while overall prescription trends saw a slight upward shift in utilization per claim and cost per claim. Even with these changes, opioids remain the #1 therapeutic class by usage and cost, however, 2019 marked the largest reduction of the last 5 years in the percentage of opioid scripts with greater than or equal to 90 MED. View the video blog here.
With the end of 2019 rapidly approaching, it is only natural to start thinking about the year ahead.
This article is authored by guest blogger, Deborah Robinson Stewart, National Manager of Medicare Set-Asides, Genex Services. In its simpl
Keep current with new legislation and its potential effect on your organization.
Keep current with new legislation and its potential effect on your organization.
Glass claims have grown increasingly complex over the past few years, and it appears that even more complexity lies ahead.
The Texas Department of Insurance recently released its annual Workers’ C